Post-approval studies (Phase 4)Study completedNCT01042392
What this trial is testing
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
Who this might be right for
Essential Hypertension
Novartis 506